Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer
Clinical Thyroidology® · 01.05.2026 · 38 (5) · 171-175
DOI: 10.1177/23299711261448628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 20.05.2026. Verfasst von Lucy Birtwistle und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Birtwistle, L., Brennan, S. C., Tsang, V., & Gild, M. L. (2026). Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer. Clinical Thyroidology®, 38(5), 171-175. https://doi.org/10.1177/23299711261448628
Vancouver
Birtwistle L, Brennan SC, Tsang V, Gild ML. Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer. Clinical Thyroidology®. 2026;38(5):171-175. doi:10.1177/23299711261448628
BibTeX
@article{Birtwistle2026,
author = {Birtwistle, Lucy and Brennan, Sarah C. and Tsang, Venessa and Gild, Matti L.},
title = {Is More Always Better? Surgical Extent and Radioactive Iodine Treatment in N1b Intermediate-High-Risk Papillary Thyroid Cancer},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {5},
pages = {171--175},
doi = {10.1177/23299711261448628}
}
EUVIMED